文献速递药疹与重症皮肤不良反应

药物诱导性超敏综合征/伴嗜酸性粒细胞增多和系统症状的药疹严重程度评分:评估疾病严重程度和预测致命性巨细胞病毒病的有用工具

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
PubMed 文献 · J Am Acad Dermatol · 2018-09-18

该回顾性分析纳入55例药物诱导性超敏综合征/伴嗜酸性粒细胞增多和系统症状的药疹(DiHS/DRESS)患者,利用临床数据建立复合评分系统。评分≥4分与后续发生巨细胞病毒(CMV)病及并发症相关,而评分<4分者无并发症发生。作者认为该评分系统可能有助于预测CMV相关并发症,对评分≥4分或证据提示CMV再激活者应考虑早期抗CMV干预。

要点

  • 评分≥4分与DiHS/DRESS患者后续发生CMV病及并发症相关。
  • 评分<4分的患者未发生并发症。
  • 作者认为评分系统可能有助于预测CMV相关并发症。

核心结论

  • 该评分系统可能有助于预测CMV相关并发症。
  • 对评分≥4分或证据提示CMV再激活的患者,应考虑早期抗CMV干预。

研究设计与样本

  • 回顾性分析55例DiHS/DRESS患者,利用临床数据建立复合评分,并按评分将患者分为3组以预测CMV再激活和并发症风险。

主要发现

  • 该评分系统可预测CMV病和并发症。
  • 评分≥4分与后续发生CMV病及并发症相关。
  • 评分<4分的患者未发生并发症。

关键数值与推荐

  • 评分≥4分与后续发生CMV病及并发症相关。
  • 评分<4分的患者未发生并发症。

临床怎么用

  • 作者认为该评分系统可能有助于预测CMV相关并发症。
  • 作者建议对评分≥4分或证据提示CMV再激活的患者考虑早期抗CMV干预。

局限性

  • 本研究为单机构研究,患者队列相对较小,且缺乏验证队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prognosis of drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is highly unpredictable. Severe complications, either related or unrelated to cytomegalovirus (CMV) reactivation, are a highly probable cause of death. OBJECTIVES: The aim was to establish a scoring system for DiHS/DRESS that can be used to monitor severity, predict prognosis, and stratify the risk of developing CMV disease and complications. METHODS: A retrospective analysis of 55 patients with DiHS/DRESS was performed. A composite score was created using clinical data. DiHS/DRESS patients were also stratified into 3 groups based on the scores to predict the risk of CMV reactivation and complications. RESULTS: This scoring system made it possible to predict CMV disease and complications. Scores ≥4 were associated with the later development of CMV disease and complications, while no patients with scores <4 developed complications. LIMITATIONS: This was a single-institution study with a relatively small patient cohort that lacked a validation cohort. CONCLUSIONS: Our scoring system may be useful for predicting CMV-related complications, and early intervention with anti-CMV agents should be considered in patients with scores ≥4 or with evidence of CMV reactivation.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Mizukawa Y, Hirahara K, Kano Y, et al. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2018. PMID: 30240780. doi:10.1016/j.jaad.2018.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。